TFC049 Solid lipid nanoparticles: a study of passive and iontophoretic permeation mechanisms through skin.
Resumo
Solid lipid nanoparticles (SLN) are drug delivery systems developed in the nineties to be an alternative to other colloidal systems like liposomes, emulsions and polymeric nanoparticles. Its use as a drug carrier for topical drug application has been vastly studied for the last years. SLN showed some promising characteristics for this use as the possibility of drug control release, small size, good stability and capacity of protection of the drug encapsulated, besides being less toxic than other drug delivery systems. Meanwhile, despite the large number of studies, there are almost no researches showing how SLN could act to improve drug penetration through the skin. In general, improved drug skin penetration is usually associated with increased hydration of stratum corneum (SC) caused by an adhesive layer (formed by SLN) occluding the skin surface. Furthermore, although intact particles are not normally considered to permeate the horny layer, some studies showed that the follicular pathway may be relevant to drug skin penetration. It is known that the follicular route is the main via of drug penetration when iontophoresis, a physical method that uses a weak electric current to increase skin drugs penetration, is applied. Therefore, iontophoresis of SLN may increase the penetration of intact SLN, increasing the encapsulated drug release inside the skin. SLN marked with hydrophilic and hydrophobic dyes at once may help to elucidate SLN skin penetration in the presence and absence of iontophoresis.Downloads
Não há dados estatísticos.
Downloads
Publicado
2012-12-27
Como Citar
HUBER, L. de A.; PEREIRA, T. A.; DE REZENDE, L. C. D.; EMERY, F. da S.; LOPEZ, R. F. V. TFC049 Solid lipid nanoparticles: a study of passive and iontophoretic permeation mechanisms through skin. Revista Eletrônica de Farmácia, Goiânia, v. 9, n. 1, p. 1, 2012. Disponível em: https://revistas.ufg.br/REF/article/view/21859. Acesso em: 16 ago. 2024.
Edição
Seção
Artigos Originais
Licença
Copyright (c) 2021 Revista Eletrônica de Farmácia
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Termo de responsabilidade de autoria e acordo de transferência do copyright, indicando a categoria do artigo, segundo as definições explicitadas nestas normas, responsabilizando os autores quanto a existência de plágio e autorizando a Revista Eletrônica de Farmácia sua publicação, devem estar assinados por todos os autores e anexado ao sistema como documento suplementar no momento de submissão do manuscrito.
Os direitos autorais da versão final do artigo são de propriedade da REF. O conteúdo da Revista ficará disponível para toda a comunidade científica.